US OptionsDetailed Quotes
ARAY250516P3000
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover356.58%IV-93.55%PremiumMay 16, 2025Expiry Date1.45Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7010Delta0.3053Gamma0.97Leverage Ratio-0.0125Theta-0.0009Rho-0.68Eff Leverage0.0011Vega
Accuray Stock Discussion
PR Newswire· 3 mins ago
Data Also Highlights Continued Clinical Advances Using the CyberKnife System That are Making
High Quality Care an Option for People Who Previously Had Limited Choices
MADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clini...
Breakthrough 25-Year Study Reveals CyberKnife's 89% Cancer Treatment Success
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
Positive
Revenue increased 8% YoY to $116.2 million
Turned $9.6M loss into $2.5M profit
Product revenue grew 19% to $61.2 million
Gross profit margin improved to 36.1% from 33.5%
Operating expenses reduced by 7%
Adjusted EBITDA increased to $9.6M from $2.0M
Raised FY2025 guidance
Negative
Service revenue declined 1% to $55.0 million
Gross product orders decreased to $76.8M from $93.9M...
just
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the TOMO® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
Thursday, 23rd January at 7:35 am
MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a pro...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you d...
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System
Monday, 13th January at 3:00 pm
MADISON, Wis., Jan. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company's Radixact SynC™ System and CyberKnife® S7™ System have been approved by the Chinese National Medical Products Adm...
No comment yet